Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway
2013 ◽
Vol 47
(11)
◽
pp. 854-868
◽
2018 ◽
Vol 104
◽
pp. 229-239
◽
2010 ◽
Vol 52
(5)
◽
pp. 727-736
◽
2019 ◽
Vol 111
◽
Keyword(s):
2016 ◽
Vol 474
(1)
◽
pp. 57-63
◽